Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
20.0%
% of OZEM's 25 holdings also in MEDX
16.7%
% of MEDX's 30 holdings also in OZEM
Overlap by Weight
Sector Drift (OZEM minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.3% | 16.4% | 15.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.2% | 5.1% | 4.2% |
|
AMGEN INC | 3.7% | 5.6% | 3.7% |
|
PFIZER INC | 3.4% | 4.1% | 3.4% |
|
REGENERON PHARMACEUTICALS | 2.5% | 3.2% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
OZEM Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 17.7% |
 |
ROCHE HOLDING LTD | 4.9% |
|
ZEALAND PHARMA A/S | 4.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.0% |
|
VIKING THERAPEUTICS, INC. | 3.8% |
 |
INNOVENT BIOLOGICS, INC. | 3.7% |
|
ALTIMMUNE, INC. | 3.4% |
 |
HANMI PHARM CO LTD | 2.8% |
|
TERNS PHARMACEUTICALS, INC. | 2.3% |
 |
THE UNITED LABORATORIES INTE | 2.0% |
OZEM Underweight Relative to MEDX
|
ABBVIE INC | -8.2% |
|
BRISTOL-MYERS SQUIBB CO | -6.1% |
|
NOVARTIS AG-ADR | -5.8% |
|
JOHNSON & JOHNSON | -4.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
 |
ALKERMES PLC | -4.3% |
|
MERCK & CO. INC. | -4.2% |
|
BIOGEN IDEC INC | -2.9% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.8% |